Minoxidil as a Prodrug: Review of Chemical, Pharmacological, and Technological Aspects in Alopecia Therapeutics

    Gustavo Terra de Oliveira, Ana Beatriz Kimie Baiocco Ikegaki, Isadora Luziana Izidoro de Souza, Sandra Barbosa Neder Agostini, Maria Betânia de Freitas Marques, Magali Benjamim De Araújo
    New to Minoxidil? There is a guide in the encyclopedia. Read the guide →
    Studysummary This review reports that pharmacogenomic variations in the SULT1A1 enzyme significantly influence the response to minoxidil treatment for alopecia, suggesting personalized therapeutic strategies could improve efficacy while emerging pharmaceutical technologies aim to optimize oral minoxidil's absorption and minimize side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →